Recommendations for specimen collection for NBOMe analysis in clinical toxicology

Justin L. PoklisDepartment of Pharmacology & Toxicology, Virginia Commonwealth University, Richmond, VA, USA

Carl E. WolfDepartment of Pathology, Virginia Commonwealth University, Richmond, VA, USA ;Department of Forensic Science, Virginia Commonwealth University, Richmond, VA, USA

Carrol R. NancoDepartment of Pathology, Virginia Commonwealth University, Richmond, VA, USA

Alphonse PoklisDepartment of Pharmacology & Toxicology, Virginia Commonwealth University, Richmond, VA, USA ;Department of Pathology, Virginia Commonwealth University, Richmond, VA, USA ;Department of Forensic Science, Virginia Commonwealth University, Richmond, VA, USACorrespondence[email protected]

References

Nikolaou P, Papoutsis I, Stefanidou M, et al. 2C-I-NBOMe, an “N-bomb” that kills with “Smiles”. Toxicological and legislative aspects. Drug Chem Toxicol. 2015;38:113–119.
PubMed Web of Science ®Google Scholar
Wood DM, Sedefov R, Cunningham A, et al. Prevalence of use and acute toxicity associated with the use of NBOMe drugs. Clin Toxicol. 2015;53:85–92.
PubMed Web of Science ®Google Scholar
Suzuki J, Dekker MA, Valenti ES, et al. Toxicities associated with NBOMe ingestion – a novel class of potent hallucinogens: a review of the literature. Psychosomatics. 2015;56:129–139.
PubMed Web of Science ®Google Scholar
Dasgupta A, Yared M. Wells A. Time dependent absorption of therapeutic drugs by the gel of Greiner Vacuette blood collection tube. Ther Drug Monitor. 2000;22:427–431.
PubMed Web of Science ®Google Scholar
Poklis JL, Dempsey SK, Liu K, et al. Identification of metabolite biomarkers of the designer hallucinogen 25I-NBOMe in mouse hepatic microsomal preparations and human urines associated with clinical intoxication. J Anal Toxicol. 2015;39:607–616.
PubMed Web of Science ®Google Scholar
Poklis JL, Clay DJ, Poklis A. High performance liquid chromatography with tandem mass spectrometry for determination of nine hallucinogenic 25-NBOMe designer drugs in urine specimens. J Anal Toxicol. 2014;38:113–121.
PubMed Web of Science ®Google Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Recommendations for specimen collection for NBOMe analysis in clinical toxicology

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Recommendations for specimen collection for NBOMe analysis in clinical toxicology

References

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date